YSB (HKSE:09885) FCF Margin % : 0.84% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is YSB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. YSB's Free Cash Flow for the six months ended in Dec. 2023 was HK$83 Mil. YSB's Revenue for the six months ended in Dec. 2023 was HK$9,848 Mil. Therefore, YSB's FCF Margin % for the quarter that ended in Dec. 2023 was 0.84%.

As of today, YSB's current FCF Yield % is 9.08%.

The historical rank and industry rank for YSB's FCF Margin % or its related term are showing as below:

HKSE:09885' s FCF Margin % Range Over the Past 10 Years
Min: -6.02 Med: -1.05 Max: 2.56
Current: 2.56

During the past 4 years, the highest FCF Margin % of YSB was 2.56%. The lowest was -6.02%. And the median was -1.05%.

HKSE:09885's FCF Margin % is ranked better than
54.02% of 672 companies
in the Healthcare Providers & Services industry
Industry Median: 1.435 vs HKSE:09885: 2.56

YSB FCF Margin % Historical Data

The historical data trend for YSB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB FCF Margin % Chart

YSB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-2.47

-6.02

0.38

2.56

YSB Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-	-2.10	2.59	4.49	0.84

Competitive Comparison of YSB's FCF Margin %

For the Pharmaceutical Retailers subindustry, YSB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where YSB's FCF Margin % falls into.

YSB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

YSB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	474.32	/	18563.917
	=	2.56 %

YSB's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	83.195	/	9847.87
	=	0.84 %

YSB FCF Margin % Related Terms

Thank you for viewing the detailed overview of YSB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB (HKSE:09885) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines